PubMedopen access
Adapted XBB.1.5 vaccine effectiveness against severe COVID-19 outcomes among immunocompromised persons in 2023-24 in six European countries: a VEBIS-EHR network study.
humans, vaccine efficacy, immunocompromised host, europe, covid-19, retrospective studies
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 409749
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.